(Stroke. 2002;33:967.)
© 2002 American Heart Association, Inc.
Original Contributions |
From the Department of Radiology and Nuclear Medicine, Akita Research Institute of Brain and Blood Vessels, Akita, Japan.
Correspondence to Hajime Tamura, Department of Radiology and Nuclear Medicine, Akita Research Institute of Brain and Blood Vessels, 6-10 Senshukubota Machi, Akita 010-0874 Japan. E-mail hajime{at}akita-noken.go.jp
| Abstract |
|---|
|
|
|---|
Methods Dynamic susceptibility contrast-enhanced MR (DSC-MR) imaging was performed within 4 hours of stroke onset in 6 patients with unilateral cerebral artery occlusion (middle cerebral artery, n=5; internal carotid artery, n=1). Cerebral blood volume was estimated on a pixel-by-pixel basis. DSC-MR images taken before arrival of the contrast medium were examined visually to identify hypointense areas. Bilateral regions of interest were set in the middle cerebral artery territory for comparison of the mean signal intensity. A semilogarithmic plot of signal intensity versus cerebral blood volume for every pixel in the region of interest was also analyzed.
Results The side on which the hypointense area was seen was significantly correlated with the side of arterial occlusion. The mean signal intensity was significantly smaller on the affected side than on the contralateral side. The semilogarithmic plot of signal intensity versus cerebral blood volume indicated greater deoxyhemoglobin concentrations for the ipsilateral than for the contralateral region of interest.
Conclusions DSC-MR images allow detection of hypointensity in the affected cerebral hemisphere in acute ischemic stroke patients. Such hypointensity may indicate increased oxygen extraction fraction (misery perfusion) and may provide information valuable to patient care.
Key Words: cerebral infarction hemoglobin magnetic resonance imaging, perfusion weighted oxygen
| Introduction |
|---|
|
|
|---|
MR imaging is a potential alternative method for detecting misery perfusion. Increased OEF should lead to increased blood deoxyhemoglobin concentrations in cerebral capillaries and veins. Because deoxyhemoglobin is paramagnetic and oxyhemoglobin is diamagnetic, changes in hemoglobin oxygenation levels affect magnetic resonance signal intensities, which are blood oxygenation level dependent.9 Relaxation times T2 and T2* decrease as deoxyhemoglobin concentrations increase, which causes MR signal reduction. T2- and T2*- sensitive MR imaging has shown a rapid reduction in signal intensity after MCA occlusion in animals.1013 The absolute T2 value also decreased in similar models.14 The change in the T2 value induced by experimental ischemia was significantly correlated with the magnitude of the blood oxygenation level-dependent effect.15 Signal reduction in T2- and T2*- sensitive MR imaging studies, however, has not been reported in acute stroke patients.
With the increasing availability of echo-planar imaging in recent years,16 dynamic susceptibility contrast-enhanced MR (DSC-MR) imaging17,18 has become a familiar clinical means of evaluating disturbances in cerebral circulation. T2* -weighted gradient-echo echo-planar imaging in DSC-MR imaging is highly T2* sensitive. In DSC-MR images obtained before the first arrival of contrast medium to the brain, signal intensity may decrease locally in brain regions with increasing deoxyhemoglobin concentrations. We tested our hypothesis that T2*-sensitive MR imaging can detect blood deoxygenation in the vascular territory of the occluded cerebral artery in patients with acute ischemic stroke.
| Subjects and Methods |
|---|
|
|
|---|
|
MR Imaging Studies
MR imaging was performed with a 1.5-T Siemens Vision system (Siemens Medical Systems) and a standard head coil. Axial fast spin-echo T2-weighted MR images [repetition time (TR), 3600 ms; echo time (TE), 96 ms; excitations, 1; slice thickness, 5 mm; slice gap, 1 mm; matrix size, 224x512; field of view, 230 mm] and 3-dimensional time-of-flight MR angiographic images (TR, 39 ms; TE, 6.5 ms; excitations, 1; slab thickness, 60 mm; partitions, 60; matrix size, 160x512; field of view, 200 mm) were acquired in 5 of the patients.
DSC-MR imaging studies were performed with axial single-shot gradient-echo echo-planar imaging (TE, 54 ms; slice thickness, 5 mm; matrix size, 128x128; field of view, 230 mm; flip angle, 90°). Immediately after a bolus injection of 0.1 mmol/kg gadolinium-chelate (Gd-DTPA) into the antecubital vein, scanning was initiated. Sixty images per slice were obtained with a 1-second TR for 60 seconds in 5 slices, 1 at the level passing through the cerebellum and the other 4 in the cerebrum obtained 0, 12, 24, and 36 mm above and parallel to the anterior commissure-posterior commissure line.
After the DSC-MR scanning, T1-weighted spin-echo images (TR, 665 ms; TE, 14 ms; excitations, 2) were obtained in 5 patients to detect leakage of the contrast medium into brain parenchyma. None of the patients showed parenchymal enhancement.
Data Analysis
Images were transferred to a UNIX workstation (Sun Ultrasparc 20) to create maps of relative cerebral blood (plasma) volume (CBVp). Signal intensity variations during bolus passage of the contrast agent were converted to a concentration-time curve fitted to a gamma variate function on a pixel-by-pixel basis, as previously described.18,19 On the basis of tracer kinetics, relative CBVp was defined as the area under the concentration-time curve and calculated with MR Vision software (MR Co). Further analysis was performed for the 2 uppermost slices because image degradation resulting from the susceptibility effect of air in the paranasal sinuses and temporal bones was noted in the lower slices.
A precontrast image was created by averaging images before arrival of the contrast medium. The first and second images were excluded from the averaging, however, because they showed different signal intensities owing to the transient magnetization. A hypointense area in the MCA territory was defined as a region of apparent decreased signal intensity on the precontrast image compared with that of the contralateral mirror region. Twelve precontrast images for 6 patients were inspected visually and independently by 2 experienced neuroradiologists who were blinded to the clinical data; they were asked to identify on which side (hemisphere) the hypointense area existed. We evaluated whether the hypointense area ultimately became infarcted by studying follow-up MR images in 5 patients and CT images in 1 patient obtained
3 days later. Volumes of the hypointense areas were outlined manually and measured for the 2 uppermost slices. Results of 2 independent observers were averaged. Corresponding volumes of final infarcts were similarly determined.
The longitudinal relaxation time, T1, was also estimated on a pixel-by-pixel basis. The signal intensity of the precontrast image depends on T1 because of the acquisitions of 1-second repetition, whereas the signal of the first image is not affected by T1. On the basis of this signal behavior, we calculated a map of T1, similar to that described elsewhere.20 In short, a shift of the flip angle of the radio frequency pulse from 90° was estimated and incorporated into a formula that expresses the signal intensity as a function of T1. The T1 map was used as a filter to segment the images. Cerebral tissue was considered to have T1 <1100 ms21 and >250 ms.
An oval region of interest (ROI) was outlined on the segmented precontrast image and on the corresponding CBVp and T1 maps in the affected MCA territory. Another ROI was placed in the mirror region in the contralateral hemisphere. The placement of ROIs is shown in Figure 1. The following numerical analysis was restricted to pixels of the segmented cerebral region in each ROI.
|
The signal intensity of the precontrast image, SIpre, depends on T2* as well as T1:
|
|
where K is a function of T1 and proton density, N. Thus, the logarithm of SIpre is a linear function of the relaxivity, R2* (=1/T2*). R2* is the sum of 2 components22: 1 component is related to both the CBV and deoxyhemoglobin concentration ([dHb]) in the blood, and the other component (B in Equation 2) depends on many other factors; ie,
|
|
where A is a proportional constant relating to magnetic field strength, vessel architecture, and water diffusion; Hct is hematocrit; and 1
ß
2.23
If we observe and plot R2* with respect to CBVp at many points in the brain, the slope of the plot will reflect [dHb] even though variations in A, Hct, and B disperse the plotted points. If A, Hct, and B in a region of the ipsilateral hemisphere are not significantly different from A, Hct, and B in the contralateral mirror region, the difference between the slopes for the 2 regions will be caused by the difference in [dHb]. To examine this relationship, the logarithm of the SIpre was plotted against CBVp for each pixel. The slope of the plot was determined by means of linear regression.
Statistical Analysis
The association between the side of hypointensity described by radiologists and the side of the occluded artery was tested by Fishers exact probability test. The difference between the mean volume of hypointense areas and that of final infarcts was analyzed by the paired ttest.
The mean SIpre, CBVp, and T1 and their SD were calculated. Values on the affected side were compared with values on the contralateral side. Slopes of the plot of log(SIpre) versus CBVp were also compared between the 2 sides. Statistical significance was determined by the paired t test across the whole patient sample. A value of P<0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
The mean SIpre of the affected side (432±30, arbitrary units) was significantly smaller than that of the contralateral side (452±32, P=0.0001). The mean CBVp of the affected side (0.36±0.18, arbitrary units) was not significantly different from that of the contralateral hemisphere (0.42±0.16). The mean T1 of the affected side (776±27 ms) was not statistically different from that of the contralateral side (774±25 ms). The slope of the semilogarithmic plot of SIpre versus CBVp for the affected side (-0.043±0.037) was significantly smaller than that for the contralateral side (0.039±0.033, P<0.0001).
| Discussion |
|---|
|
|
|---|
The signal intensity of DSC-MR images depends on T1 and T2* of the tissue of interest (see Equation 1). T2* of brain tissue is a function of CBV and [dHb] (see Equation 2). Because there was no statistically significant difference in T1 and CBVp between the affected and the contralateral hemispheres in the present study, the factor contributing most to the reduction of local SIpre hypointensity was considered to be the increased [dHb] in the vascular territory of the occluded artery.
The origin of observed signal intensity change was further examined in a pixel-by-pixel analysis of the relationship between CBVp and SIpre. In this analysis, the slope of the semilogarithmic plot of SIpre versus CBVp for the affected hemisphere was significantly smaller than that of the contralateral hemisphere. In Equation 2, A and ß depend on blood vessel architecture within a voxel.23 Because there was no significant difference in CBVp between the affected and contralateral hemispheres, the same values of A and ß can be applied for both hemispheres. Although Hct in capillaries and veins in the ischemic area was significantly lower than that in normal brain areas in experimental studies,24 R2* decreases as Hct decreases if the other parameters in Equation 2 are fixed. The decrease in R2* will cause an increase in SIpre (see Equation 1). Therefore, the decrease in the slope of the SIpre versus CBVp plot in the affected region was not caused by the change in Hct. B in Equation 2 is related to T2 and local heterogeneity of the magnetic field produced by sources independent of the blood oxygenation level. Because no apparent difference between the ipsilateral and contralateral hemispheres was observed on fast spin-echo T2-weighted images (Figures 1 and 2; an unavoidable partial volume effect from hyperintense cerebrospinal fluid precluded quantitative ROI-based analysis for spin-echo T2-weighted images), T2 may not differ significantly between the symmetrical mirror regions of the hemispheres. (A reduction in T2, as observed in experimental studies,14 may be too small to detect on the present T2-weighted images at 1.5 T.) Local field inhomogeneity also may not differ significantly between hemispheres because of the anatomic symmetry. Thus, the decrease in the slope of the SIpre versus CBVp plot for the affected hemisphere probably is due to an increase in [dHb]. This further confirms that the hypointense signal in T2*-sensitive MR images of the affected hemisphere was induced by the elevated deoxyhemoglobin level of the circulating blood.
Brain lesions associated with hypointense T2*-sensitive images became infarcted in all but patient 3. One patient with a normal T2*-weighted image escaped infarction. The increased OEF, corresponding to the hypointense T2*-sensitive image, has been studied by means of PET in relation to the evolution of infarction. Marchal et al25 investigated OEF in acute stroke patients. In their study, an increased OEF (0.753±0.152) was found up to 17 hours after stroke onset. The cerebral metabolic rate of oxygen (CMRO2) ranged from 1.55 to 2.23 mL · 100 g-1 · min-1, which is well above the value of 1.30 mL · 100 g-1 · min-1 accepted as the CMRO2 threshold for infarction.26 The lesions in their patients, however, evolved into infarction at the chronic stage. Several studies also demonstrated metabolic derangement and evolution of infarction in brain regions with increased OEF during the subacute and chronic stages.6,7 Thus, an increased OEF or a hypointense T2*-sensitive image may indicate a high risk of infarction, although an increased OEF by itself may not be an accurate predictor of the occurrence of infarction.5 In several animal experiments, however, infarction was prevented or reduced in size when the occluded artery was reopened.3,27 These findings and the experience of our patient 3 indicate that brain regions demonstrating a hypointense signal on a T2*-sensitive image may be a target for acute therapy to improve compromised cerebral circulation.
There are 2 different situations in the misery perfusion syndrome.1 One is a chronic syndrome in patients with severe carotid artery disease in whom a modest reduction in CBF is associated with normally maintained oxygen metabolism. This may persist for a long period of time. The other is an acute syndrome in patients with brain embolism investigated in this study in which the tissue is undergoing the process of infarction.57 It remains unproven that the T2*-sensitive MR imaging can detect hypointensity related to blood deoxygenation in chronic misery perfusion syndrome.
There were several limitations to T2*-sensitive MR imaging in detecting brain areas containing deoxygenated blood. As noted previously, susceptibility artifact from air interfered with the detection of true signal change. Side-by-side comparison was done to identify hypointense signal intensity in T2*-sensitive images. This is not appropriate in patients with coexisting brain lesions, however. The signal intensity of T2*-sensitive images is influenced by the pathological nature of the tissue (eg, hemosiderin deposition, leukoaraiosis, and old infarction) represented by B in Equation 2. The OEF of PET, an indicator of misery perfusion, is quantitative, but the hypointense signal intensity of T2*-sensitive images is qualitative at present.
Despite these limitations, DSC-MR T2*-sensitive images before the first arrival of contrast medium to the brain may be valuable in identifying misery perfusion previously detected only by PET. It should be analyzed in relation to ischemic penumbra determined by a mismatch between perfusion and diffusion in MR study. Further validation of T2* -sensitive MR imaging compared with PET OEF study in a larger patient population is needed.
In conclusion, our data suggest that use of DSC-MR images before the arrival of the contrast agent enables detection of hypointensity caused by deoxygenation in the affected cerebral hemisphere of acute ischemic stroke patients. Such hypointensity may be an index of misery perfusion and may provide useful information for the determination of appropriate patient therapy. These preliminary data describe a relative and not yet quantifiable index of oxygen extraction, the relevance of which must be proven compared with diffusion and perfusion MRI and with quantitative PET studies.
| Acknowledgments |
|---|
Received April 10, 2001; revision received July 2, 2001; accepted July 24, 2001.
| References |
|---|
|
|
|---|
2. Heiss WD. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab. 2000; 20: 12761293.[CrossRef][Medline] [Order article via Infotrieve]
3. Heiss WD, Graf R, Löttgen J, Ohta K, Fujita T, Wagner R, Grond M, Weinhard K. Repeat positron emission tomographic studies in transient middle cerebral artery occlusion in cats: residual perfusion and efficacy of postischemic reperfusion. J Cereb Blood Flow Metab. 1997; 17: 388400.[CrossRef][Medline] [Order article via Infotrieve]
4. Heiss WD, Fink GR, Huber M, Herholz K. Positron emission tomography imaging and the therapeutic window. Stroke. 1993; 24 (suppl): I50I53.
5. Furlan M, Marchal G, Viader F, Derlon JM, Baron JC. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol. 1996; 40: 216226.[CrossRef][Medline] [Order article via Infotrieve]
6.
Wise RJ, Bernardi S, Frackowiak RS, Legg NJ, Jones T. Serial observations on the pathophysiology of acute stroke: the transition from ischaemia to infarction as reflected in regional oxygen extraction. Brain. 1983; 106: 197222.
7. Hakim AM, Evans AC, Berger L, Kuwabara H, Worsley K, Marchal G, Biel C, Pokrupa R, Diksic M, Meyer E, et al. The effect of nimodipine on the evolution of human cerebral infarction studied by PET. J Cereb Blood Flow Metab. 1989; 9: 523534.[Medline] [Order article via Infotrieve]
8. Heiss WD, Huber M, Fink GR, Herholz K, Pietrzyk U, Wagner R, Wienhard K. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab. 1992; 12: 193203.[Medline] [Order article via Infotrieve]
9. Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med. 1990; 14: 6878.[Medline] [Order article via Infotrieve]
10. De Crespigny AJ, Wendland MF, Derugin N, Kozniewska E, Moseley ME. Real-time observation of transient focal ischemia and hyperemia in cat brain. Magn Reson Med. 1992; 27: 391397.[Medline] [Order article via Infotrieve]
11. Quast MJ, Huang NC, Hillman GR, Kent TA. The evolution of acute stroke recorded by multimodal magnetic resonance imaging. Magn Reson Imaging. 1993; 11: 465471.[CrossRef][Medline] [Order article via Infotrieve]
12. Roussel SA, van Bruggen N, King MD, Gadian DG. Identification of collaterally perfused areas following focal cerebral ischemia in the rat by comparison of gradient echo and diffusion- weighted MRI. J Cereb Blood Flow Metab. 1995; 15: 578586.[Medline] [Order article via Infotrieve]
13. Dijkhuizen RM, Berkelbach van der Sprenkel JW, Tulleken KA, Nicolay K. Regional assessment of tissue oxygenation and the temporal evolution of hemodynamic parameters and water diffusion during acute focal ischemia in rat brain. Brain Res. 1997; 750: 161170.[CrossRef][Medline] [Order article via Infotrieve]
14. Gröhn OH, Lukkarinen JA, Oja JM, van Zijl PC, Ulatowski JA, Traystman RJ, Kauppinen RA. Noninvasive detection of cerebral hypoperfusion and reversible ischemia from reductions in the magnetic resonance imaging relaxation time, T2. J Cereb Blood Flow Metab. 1998; 18: 911920.[CrossRef][Medline] [Order article via Infotrieve]
15. Gröhn OH, Kettunen MI, Penttonen M, Oja JM, van Zijl PC, Kauppinen RA. Graded reduction of cerebral blood flow in rat as detected by the nuclear magnetic resonance relaxation time T2: a theoretical and experimental approach. J Cereb Blood Flow Metab. 2000; 20: 316326.[CrossRef][Medline] [Order article via Infotrieve]
16.
Edelman RR, Wielopolski P, Schmitt F. Echo-planar MR imaging. Radiology. 1994; 192: 600612.
17. Villringer A, Rosen BR, Belliveau JW, Ackerman JL, Lauffer RB, Buxton RB, Chao YS, Wedeen VJ, Brady TJ. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med. 1988; 6: 164174.[Medline] [Order article via Infotrieve]
18. Belliveau JW, Rosen BR, Kantor HL, Rzedzian RR, Kennedy DN, McKinstry RC, Vevea JM, Cohen MS, Pykett IL, Brady TJ. Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med. 1990; 14: 538546.[Medline] [Order article via Infotrieve]
19. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med. 1990; 14: 249265.[Medline] [Order article via Infotrieve]
20. Tamura H, Yanagawa I, Hikichi T, Matsumoto K, Takahashi S, Sakamoto K. T1 measurements with clinical MR units. Tohoku J Exp Med. 1995; 175: 249267.[Medline] [Order article via Infotrieve]
21. Steen RG, Gronemeyer SA, Kingsley PB, Reddick WE, Langston JS, Taylor JS. Precise and accurate measurement of proton T1 in human brain in vivo: validation and preliminary clinical application. J Magn Reson Imaging. 1994; 4: 681691.[Medline] [Order article via Infotrieve]
22. Hoge RD, Atkinson J, Gill B, Crelier GR, Marrett S, Pike GB. Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: the deoxyhemoglobin dilution model. Magn Reson Med. 1999; 42: 849863.[CrossRef][Medline] [Order article via Infotrieve]
23. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med. 1995; 34: 555566.[Medline] [Order article via Infotrieve]
24. Mchedlishvili G, Varazashvili M. Hematocrit in cerebral capillaries and veins under control and ischemic conditions. J Cereb Blood Flow Metab. 1987; 7: 739744.[Medline] [Order article via Infotrieve]
25.
Marchal G, Beaudouin V, Rioux P, de la Sayette V, Le Doze F, Viader F, Derlon JM, Baron JC. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke. 1996; 27: 599606.
26. Powers WJ, Grubb RL Jr, Darriet D, Raichle ME. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab. 1985; 5: 600608.[Medline] [Order article via Infotrieve]
27. Young AR, Sette G, Touzani O, Rioux P, Derlon JM, MacKenzie ET, Baron JC. Relationships between high oxygen extraction fraction in the acute stage and final infarction in reversible middle cerebral artery occlusion: an investigation in anesthetized baboons with positron emission tomography. J Cereb Blood Flow Metab. 1996; 16: 11761188.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
D. Kaya, A. Dincer, M.E. Yildiz, M.O. Cizmeli, and C. Erzen Acute Ischemic Infarction Defined by a Region of Multiple Hypointense Vessels on Gradient-Echo T2* MR Imaging at 3T AJNR Am. J. Neuroradiol., June 1, 2009; 30(6): 1227 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Siemonsen, J. Finsterbusch, J. Matschke, A. Lorenzen, X.-Q. Ding, and J. Fiehler Age-Dependent Normal Values of T2* and T2' in Brain Parenchyma AJNR Am. J. Neuroradiol., May 1, 2008; 29(5): 950 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Geisler, F. Brandhoff, J. Fiehler, C. Saager, O. Speck, J. Rother, H. Zeumer, and T. Kucinski Blood Oxygen Level-Dependent MRI Allows Metabolic Description of Tissue at Risk in Acute Stroke Patients Stroke, July 1, 2006; 37(7): 1778 - 1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hermier, N. Nighoghossian, L. Derex, M. Wiart, C. Nemoz, Y. Berthezene, and J. C. Froment Hypointense leptomeningeal vessels at T2*-weighted MRI in acute ischemic stroke Neurology, August 23, 2005; 65(4): 652 - 653. [Full Text] [PDF] |
||||
![]() |
M. Hermier and N. Nighoghossian Contribution of Susceptibility-Weighted Imaging to Acute Stroke Assessment Stroke, August 1, 2004; 35(8): 1989 - 1994. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |